Literature DB >> 33708477

Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation.

Xue-Dong Wang1, Jing Liu1, Yu-Chen Zhang2, Yu Wang1, Yan Wang1, Dan Ma1.   

Abstract

BACKGROUND: The aim of the present study was to investigate the correlation between the elevated uric acid (UA) levels and activation of the circulating renin-angiotensin-aldosterone system (RAAS) in patients with atrial fibrillation (AF).
METHODS: A total of 233 outpatients and inpatients of the Cardiology Department from January 1, 2019, to December 31, 2019, were selected and divided into the sinus rhythm group (SR) with 84 cases, the paroxysmal AF group (pAF) with 76 cases, and the persistent AF group (PAF) with 73 patients. The general clinical data and the serum levels of UA of the enrolled patients were collected, and the radioimmunoassay was adopted to detect the levels of renin (Renin), angiotensin II (Ang II), and aldosterone (Ald).
RESULTS: Renin, AngII, Ald, and UA in the PAF group were significantly higher than those in the pAF group, and the levels of the above indicators in the pAF group were significantly higher than those in the SR group (P<0.001). The left atrium anteroposterior diameter (LAD) and the left ventricular end-diastolic diameter (LVEDD) were significantly increased in the PAF group (P<0.001). The Pearson correlation analysis showed that the levels of the high sensitivity C-reactive protein (hsCRP), AngII Renin, Ald, LVEDD, and LAD were positively correlated with the serum levels of UA (r=0.174, 0.273, 0.34, 0.385, 0.138, respectively, P<0.05 in all). The left ventricular ejection fraction (LVEF) was negatively correlated with the UA level (r=-0.177, P<0.05). Multiple linear regression analysis showed that UA (β=0.103) and LAD (β=2.162) were independent risk factors for Renin. The independent risk factor for Ang II was UA (β=0.167). The independent risk factor for Ald was UA (β=0.283) and LAD (β=8.721) (P<0.05).
CONCLUSIONS: Elevated UA might cause excessive activation of the RAAS, aggravate the oxidative stress, and participate in the atrial remodeling, thereby promoting the occurrence and persistence of AF. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Uric acid (UA); atrial fibrillation (AF); renin-angiotensin-aldosterone system (RAAS)

Year:  2021        PMID: 33708477      PMCID: PMC7944194          DOI: 10.21037/cdt-20-830

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  22 in total

Review 1.  Hyperuricemia and Atrial Fibrillation.

Authors:  Nani Maharani; Masanari Kuwabara; Ichiro Hisatome
Journal:  Int Heart J       Date:  2016-07-11       Impact factor: 1.862

2.  Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.

Authors:  W Y Liang; W W Liu; M L Liu; W Xiang; X R Feng; B Huang; X H Chen; Y S Sun
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-03-31       Impact factor: 4.222

Review 3.  Uric acid and cardiovascular disease.

Authors:  Gjin Ndrepepa
Journal:  Clin Chim Acta       Date:  2018-05-24       Impact factor: 3.786

Review 4.  Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years.

Authors:  Barbara Cybulska; Longina Kłosiewicz-Latoszek
Journal:  Kardiol Pol       Date:  2019       Impact factor: 3.108

5.  Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.

Authors:  Dalila B Corry; Pirooz Eslami; Kei Yamamoto; Michael D Nyby; Hirofumi Makino; Michael L Tuck
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

6.  Serum Uric Acid and Atrial Fibrillation: Meta-analysis.

Authors:  Stella Pak; Yan Yatsynovich; Damian Valencia; Tian Chen
Journal:  Crit Pathw Cardiol       Date:  2018-09

Review 7.  The pathogenesis of cardiac fibrosis.

Authors:  Ping Kong; Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Cell Mol Life Sci       Date:  2013-05-07       Impact factor: 9.261

8.  Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.

Authors:  Kalkidan Bishu; Anita Deswal; Horng H Chen; Martin M LeWinter; Gregory D Lewis; Marc J Semigran; Barry A Borlaug; Steven McNulty; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Am Heart J       Date:  2012-10-16       Impact factor: 4.749

Review 9.  Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes.

Authors:  Stacy Westerman; Nanette Wenger
Journal:  Curr Cardiol Rev       Date:  2019

10.  The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study.

Authors:  Li-Hua Li; Chang-Sheng Sheng; Bang-Chuan Hu; Qi-Fang Huang; Wei-Fang Zeng; Ge-Le Li; Ming Liu; Fang-Fei Wei; Lu Zhang; Yuan-Yuan Kang; Jie Song; Shuai Wang; Yan Li; Shao-Wen Liu; Ji-Guang Wang
Journal:  BMC Cardiovasc Disord       Date:  2015-05-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.